208 related articles for article (PubMed ID: 35266849)
1. Molecular Targets of Curcumin and Its Therapeutic Potential for Ovarian Cancer.
Mohamadian M; Bahrami A; Moradi Binabaj M; Asgharzadeh F; Ferns GA
Nutr Cancer; 2022; 74(8):2713-2730. PubMed ID: 35266849
[TBL] [Abstract][Full Text] [Related]
2. Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.
Terlikowska KM; Witkowska AM; Zujko ME; Dobrzycka B; Terlikowski SJ
Int J Mol Sci; 2014 Nov; 15(12):21703-22. PubMed ID: 25429431
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets of curcumin in breast cancer (Review).
Song X; Zhang M; Dai E; Luo Y
Mol Med Rep; 2019 Jan; 19(1):23-29. PubMed ID: 30483727
[TBL] [Abstract][Full Text] [Related]
4. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
[TBL] [Abstract][Full Text] [Related]
5. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of curcumin via fascin suppression through JAK/STAT3 pathway on metastasis and recurrence of ovary cancer cells.
Kim MJ; Park KS; Kim KT; Gil EY
BMC Womens Health; 2020 Nov; 20(1):256. PubMed ID: 33213437
[TBL] [Abstract][Full Text] [Related]
7. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
8. Gemini Curcumin Suppresses Proliferation of Ovarian Cancer OVCAR-3 Cells via Induction of Apoptosis.
Ghaderi S; Babaei E; Hussen BM; Mahdavi M; Azeez HJ
Anticancer Agents Med Chem; 2021; 21(6):775-781. PubMed ID: 32767955
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
10. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
[TBL] [Abstract][Full Text] [Related]
11. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
12. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells.
Liu LD; Pang YX; Zhao XR; Li R; Jin CJ; Xue J; Dong RY; Liu PS
Arch Gynecol Obstet; 2019 Jun; 299(6):1627-1639. PubMed ID: 31006841
[TBL] [Abstract][Full Text] [Related]
14. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways.
Wang H; Zhang K; Liu J; Yang J; Tian Y; Yang C; Li Y; Shao M; Su W; Song N
Front Oncol; 2021; 11():660712. PubMed ID: 33912467
[TBL] [Abstract][Full Text] [Related]
16. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
17. The targets of curcumin.
Zhou H; Beevers CS; Huang S
Curr Drug Targets; 2011 Mar; 12(3):332-47. PubMed ID: 20955148
[TBL] [Abstract][Full Text] [Related]
18. Modulation of microRNAs expression and cellular signaling pathways through curcumin as a potential therapeutical approach against ovarian cancer: A review.
Moazzami B; Chaichian S; Nikfar B; Arbabi Bidgoli S
Pathol Res Pract; 2023 Jul; 247():154527. PubMed ID: 37235907
[TBL] [Abstract][Full Text] [Related]
19. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers.
Ashrafizadeh M; Zarrabi A; Hashemipour M; Vosough M; Najafi M; Shahinozzaman M; Hushmandi K; Khan H; Mirzaei H
Pharmacol Res; 2020 Oct; 160():105199. PubMed ID: 32942019
[TBL] [Abstract][Full Text] [Related]
20. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
Srivastava NS; Srivastava RAK
Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
